ST266 Eyedrops for the Treatment of Persistent Corneal Epithelial Defects

Clinical trial NCT05066698 · TERMINATED

Trial details

NCT number: NCT05066698
Sponsor: Noveome Biotherapeutics, formerly Stemnion
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Persistent Corneal Epithelial Defect

Start date: 2022-04-27
Primary completion: 2022-09-07
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.